Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells ...

JMP Securities raised the price target for the Adicet Bio Inc (NASDAQ:ACET) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on June 27, 2023, according to finviz. The ...

ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the first quarter of 2024.More From ...

Dr. Kingsley Y. Amoako, Founder and President of the African Center for Economic Transformation (ACET) Thursday said Ghana ...

Accelerating Community Energy Transformation (ACET) is moving Canada closer to a net-zero future by supporting local, ...

The National Commission for Civic Education (NCCE), in collaboration with the Africa Center for Economic Transformation (ACET ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Precision BioSciences (DTIL – Research ...

In a report released today, Reni Benjamin from JMP Securities maintained a Hold rating on Adicet Bio (ACET – Research Report). The ...

African economies have become less diversified and the competitiveness of their exports has declined, leaving the continent ...